Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey
- PMID: 7811529
Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey
Abstract
Chronic Pseudomonas aeruginosa lung infection is responsible for most of the mortallity and morbility observed in cystic fibrosis patients. During the course of the disease, the bacteria change from being O-serogroup typable (monoagglutinable), non-mucoid, resistant to normal human serum and motile, to become O-serogroup non-typable (polyagglutinable), serum-sensitive and non-motile. In spite of high levels of antibodies produced by the patient, and intensive antibiotic therapy it is not possible to eradiate the polyagglutinable bacteria from the lungs of the patients. The bacteria will reappear and it is not fully understood if it is the same strain which reappears, or it is a super-infection with a new strain which takes place. A reliable and stable typing method is needed to clarify this question. In the present study, the conventional typing methods, such as serotyping, phage typing and pyocin typing were compared with the newer DNA typing methods, such as, restriction fragment length polymorphism (RFLP) in combination with pulsed field gel electrophoresis (PFGE) and typing with a specific DNA probe. Typability, reproducibility and discriminatory power using the different typing methods were investigated. The conventional typing methods have proved to be adequate when typing P. aeruginosa isolates from non cystic fibrosis sources, but because the majority of cystic fibrosis P. aeruginosa isolates are polyagglutinable or non typable, serotyping is not useful. Phage typing also lacks discriminatory power as it lumps up to 40% of the isolates in the same phage group. Pyocin typing has the disadvantage of low reproducibility. Most of the conventional typing methods are based on receptors on the bacterial surface, which on exposure to the environmental conditions in the lung, are likely to provoke phenotypic changes of the bacteria. The obvious advantage of the newer DNA typing methods is that these methods are based on internal properties of the bacteria, as part of the bacterial genome is investigated. The present study has revealed that for the time being, restriction fragment length polymorphism (RFLP) and pulsed field gel electrophoresis (PFGE) in combination with phage typing is the best method of typing P. aeruginosa isolates from cystic fibrosis patients for epidemiological purposes.
Similar articles
-
Typing of polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.APMIS. 1990 May;98(5):423-31. APMIS. 1990. PMID: 2113398
-
Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.APMIS. 1991 Jun;99(6):492-8. APMIS. 1991. PMID: 1905144
-
Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.APMIS. 1993 Feb;101(2):168-75. APMIS. 1993. PMID: 8098219
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
-
[Various typing methods of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients].Med Mal Infect. 2008 May;38(5):238-47. doi: 10.1016/j.medmal.2008.02.005. Epub 2008 Apr 3. Med Mal Infect. 2008. PMID: 18394837 Review. French.
Cited by
-
Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis.Paediatr Drugs. 2000 Nov-Dec;2(6):451-63. doi: 10.2165/00128072-200002060-00004. Paediatr Drugs. 2000. PMID: 11127845 Review.
-
Application of Whole-Genome Sequencing Data for O-Specific Antigen Analysis and In Silico Serotyping of Pseudomonas aeruginosa Isolates.J Clin Microbiol. 2016 Jul;54(7):1782-1788. doi: 10.1128/JCM.00349-16. Epub 2016 Apr 20. J Clin Microbiol. 2016. PMID: 27098958 Free PMC article.
-
Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats.J Bacteriol. 1996 Jan;178(1):85-93. doi: 10.1128/jb.178.1.85-93.1996. J Bacteriol. 1996. PMID: 8550447 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical